ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The US Food and Drug Administration has approved the first T-cell therapy for solid tumors. The therapies could previously be used only to treat blood cancers. The FDA approved Amtagvi, developed by Iovance Biotherapeutics, for patients with advanced melanoma and has also given the green light to WuXi Advanced Therapies’ Philadelphia site to make the drug, which is produced from a patient’s own cancer cells.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter